Xtant Medical Holdings, Inc. (XMS.SG)

0.4420

+0.0220

+(5.24%)

At close: April 30 at 9:43:57 PM GMT+2

Xtant Medical Launches Trivium™ Advanced Bone Graft for Superior Performance

Xtant Medical Holdings, Inc.(NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthopedic and woundcare disorders, is proud to announce the launch of Trivium™, a premium, next-generation demineralized bone matrix (DBM) allograft designed to elevate the standard of care in bone grafting procedures. Engineered with advanced PureLoc™ Fiber Technology, Trivium combines three synergistic elements intended to deliver exceptional perform

PR Newswire 8 days ago

XTNT
Xtant Medical Announces Secondary Private Sale of Existing Shares by OrbiMed and Preliminary First Quarter 2025 Revenue Growth of 18% to 19%

Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthopedic and woundcare disorders, today announced the completion of a secondary private sale of 73.1 million shares of Xtant common stock held by funds affiliated with OrbiMed Advisors LLC ("OrbiMed") to several existing and new stockholders, led by Nantahala Capital Management LLC ("Nantahala").

PR Newswire 15 days ago

XTNT
Xtant Medical Reports Fourth Quarter and Full Year 2024 Financial Results

Full Year 2024 Revenue Growth of 28% Expects 2025 Revenue of $126 Million to $130 Million Without Need for Additional Capital BELGRADE, MT / ACCESS Newswire / March 6, 2025 /Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology ...

ACCESS Newswire last month

XTNT
Xtant Medical to Issue Fourth Quarter and Year End 2024 Financial Results on March 6, 2025

BELGRADE, MT / ACCESS Newswire / February 28, 2025 /Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its ...

ACCESS Newswire 2 months ago

XTNT
US Penny Stocks: 3 Picks With Market Caps As Low As $70M

The U.S. stock market has recently experienced a pullback after record highs in the S&P 500, reflecting ongoing volatility amid mixed corporate earnings and economic policy shifts. Penny stocks, though considered an older term, still hold significant potential for investors looking to explore opportunities in smaller or newer companies. These stocks can offer a blend of affordability and growth potential when they exhibit strong financials, making them intriguing options for those seeking to...

Simply Wall St. 2 months ago

XTNT

MAPS

MAPSW
US Penny Stocks To Watch In January 2025

As the U.S. stock market reaches new heights, with major indices like the S&P 500 and Nasdaq surging on the back of strong earnings and AI-driven optimism, investors are increasingly exploring diverse investment opportunities. Penny stocks, while often considered speculative, can still offer significant potential when backed by solid financials and growth prospects. These smaller or newer companies may present unique opportunities for value at lower price points, making them an intriguing...

Simply Wall St. 3 months ago

MAPS

MAPSW

XTNT
3 US Penny Stocks With Market Caps Under $300M

As the U.S. stock market experiences a Santa Claus Rally, with major indices like the Nasdaq Composite and S&P 500 posting gains, investors are turning their attention to various opportunities within the market. Penny stocks, despite being an older term, remain relevant for those seeking affordable entry points into potentially high-growth companies. These smaller or newer firms can offer unique growth potential when supported by robust financials, making them intriguing options for investors...

Simply Wall St. 4 months ago

ZNTL

OCC

XTNT
Xtant Medical Reports Third Quarter 2024 Financial Results

Third Quarter Revenue Growth of 12% Reaffirms Full Year 2024 Revenue Guidance of $116 Million to $120 Million Representing Growth of 27% to 31% BELGRADE, MT / ACCESSWIRE / November 12, 2024 /Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global ...

ACCESS Newswire 5 months ago

XTNT
Xtant Medical to Attend the 15th Annual Craig-Hallum Alpha Select Conference

BELGRADE, MT / ACCESSWIRE / November 11, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced announced that Sean Browne, ...

ACCESS Newswire 5 months ago

XTNT
Xtant Medical to Issue Third Quarter 2024 Financial Results on November 12, 2024

BELGRADE, MT / ACCESSWIRE / November 7, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial ...

ACCESS Newswire 5 months ago

XTNT
Xtant Medical Expands Product Portfolio with the Launch of the Cortera(R) Posterior Fixation System

New System Enhances Surgical Efficiency and Provides Versatile Solutions for Complex Spine Procedures BELGRADE, MT / ACCESSWIRE / September 23, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a leading global medical technology company focused ...

ACCESS Newswire 7 months ago

XTNT
Xtant Medical Expands Product Portfolio with Launch of its own Viable Bone Matrix, OsteoVive(R) Plus

New Cellular Bone Matrix Designed with Cohesive and Moldable Handling Characteristics BELGRADE, MT / ACCESSWIRE / September 18, 2024 /Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions ...

ACCESS Newswire 7 months ago

XTNT
Xtant Medical Announces $5.0 Million Private Placement

BELGRADE, MT / ACCESSWIRE / August 8, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced it has entered into a securities ...

ACCESS Newswire 8 months ago

XTNT
Xtant Medical to Host Second Quarter 2024 Financial Results Earnings Conference call on August 9, 2024

BELGRADE, MT / ACCESSWIRE / August 8, 2024 /Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial ...

ACCESS Newswire 8 months ago

XTNT
Xtant Medical Reports Second Quarter 2024 Revenue Growth of 48%

BELGRADE, MT / ACCESSWIRE / August 8, 2024 /Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results ...

ACCESS Newswire 8 months ago

XTNT
Xtant Medical to Present at the Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase

BELGRADE, MT / ACCESSWIRE / July 25, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that Sean Browne, President and ...

ACCESS Newswire 9 months ago

XTNT
Xtant Medical to Participate in 21st Annual Craig-Hallum Institutional Investor Conference on May 29

BELGRADE, MT / ACCESSWIRE / May 22, 2024 /Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that Sean Browne, President and Chief ...

ACCESS Newswire 11 months ago

XTNT
Xtant Medical Reports First Quarter 2024 Revenue Growth of 55% and Raises Full Year 2024 Revenue Guidance

Expects Revenue for Full Year 2024 of $116 Million to $120 Million BELGRADE, MT / ACCESSWIRE / May 15, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of ...

ACCESS Newswire 11 months ago

XTNT
Xtant Medical to Issue First Quarter 2024 Financial Results on May 15, 2024

BELGRADE, MO / ACCESSWIRE / May 8, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial ...

ACCESS Newswire 11 months ago

XTNT

Performance Overview

Return	XMS.SG	S&P 500 (^GSPC)
YTD	+6.76%	-4.72%
1-Year	-45.43%	+11.67%
3-Year	-21.77%	+35.63%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Live

Xtant Medical Holdings, Inc. (XMS.SG)

Xtant Medical Launches Trivium™ Advanced Bone Graft for Superior Performance

Xtant Medical Announces Secondary Private Sale of Existing Shares by OrbiMed and Preliminary First Quarter 2025 Revenue Growth of 18% to 19%

Xtant Medical Reports Fourth Quarter and Full Year 2024 Financial Results

Xtant Medical to Issue Fourth Quarter and Year End 2024 Financial Results on March 6, 2025

US Penny Stocks: 3 Picks With Market Caps As Low As $70M

US Penny Stocks To Watch In January 2025

3 US Penny Stocks With Market Caps Under $300M

Xtant Medical Reports Third Quarter 2024 Financial Results

Xtant Medical to Attend the 15th Annual Craig-Hallum Alpha Select Conference

Xtant Medical to Issue Third Quarter 2024 Financial Results on November 12, 2024

Xtant Medical Expands Product Portfolio with the Launch of the Cortera(R) Posterior Fixation System

Xtant Medical Expands Product Portfolio with Launch of its own Viable Bone Matrix, OsteoVive(R) Plus

Xtant Medical Announces $5.0 Million Private Placement

Xtant Medical to Host Second Quarter 2024 Financial Results Earnings Conference call on August 9, 2024

Xtant Medical Reports Second Quarter 2024 Revenue Growth of 48%

Xtant Medical to Present at the Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase

Xtant Medical to Participate in 21st Annual Craig-Hallum Institutional Investor Conference on May 29

Xtant Medical Reports First Quarter 2024 Revenue Growth of 55% and Raises Full Year 2024 Revenue Guidance

Xtant Medical to Issue First Quarter 2024 Financial Results on May 15, 2024

Performance Overview